clarithromycin has been researched along with hydroxychloroquine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Donta, ST | 1 |
| Berende, A; Donders, AR; Evers, AW; Kullberg, BJ; ter Hofstede, HJ; Tromp, M; van den Hoogen, FH; van Middendorp, H; Vogelaar, ML; Vos, FJ | 1 |
| Auwaerter, PG; Melia, MT | 1 |
| Steurer, J | 1 |
| Adang, EMM; Berende, A; Donders, ART; Evers, AWM; Kullberg, BJ; Nieuwenhuis, L; Ter Hofstede, HJM; Tromp, M; van Middendorp, H; Vogelaar, ML; Vos, FJ | 1 |
| Berende, A; Evers, AWM; Kessels, RPC; Kullberg, BJ; Ter Hofstede, HJM; van Middendorp, H; Vogelaar, ML; Vos, FJ | 1 |
1 review(s) available for clarithromycin and hydroxychloroquine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for clarithromycin and hydroxychloroquine
| Article | Year |
|---|---|
Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease.
Topics: Adult; Anti-Bacterial Agents; Antimalarials; Clarithromycin; Double-Blind Method; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Infusions, Intravenous; Intention to Treat Analysis; Lyme Disease; Male; Middle Aged; Quality of Life | 2016 |
[Months of antibiotic therapy in persistent symptoms of Lyme disease without effect].
Topics: Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Dose-Response Relationship, Drug; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Long-Term Care; Lyme Disease; Male; Middle Aged; Quality of Life | 2016 |
Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease.
Topics: Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Cost-Benefit Analysis; Double-Blind Method; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Lyme Disease; Male; Middle Aged; Quality-Adjusted Life Years; Time Factors; Treatment Outcome | 2018 |
Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Chronic Disease; Clarithromycin; Cognition; Double-Blind Method; Doxycycline; Female; Humans; Hydroxychloroquine; Lyme Disease; Male; Middle Aged; Neuropsychological Tests | 2019 |
3 other study(ies) available for clarithromycin and hydroxychloroquine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Macrolide therapy of chronic Lyme Disease.
Topics: Anti-Bacterial Agents; Borrelia burgdorferi; Clarithromycin; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Hydroxychloroquine; Lyme Disease; Macrolides; Treatment Outcome | 2003 |
Time for a Different Approach to Lyme Disease and Long-Term Symptoms.
Topics: Anti-Bacterial Agents; Antimalarials; Clarithromycin; Doxycycline; Female; Humans; Hydroxychloroquine; Lyme Disease; Male | 2016 |